90 related articles for article (PubMed ID: 28272681)
1. Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features.
Venkatachala S; Rajendran M
Turk Patoloji Derg; 2017; 33(3):228-234. PubMed ID: 28272681
[TBL] [Abstract][Full Text] [Related]
2. Expression of COX-2 and HER-2 in colorectal cancer and their correlation.
Wu QB; Sun GP
World J Gastroenterol; 2015 May; 21(20):6206-14. PubMed ID: 26034355
[TBL] [Abstract][Full Text] [Related]
3. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters.
Wu CY; Lee WH; Wang JY; Chiang H; Chang JL; Tsai WC; Sheu LF; Jin JS
Chin J Physiol; 2006 Dec; 49(6):298-304. PubMed ID: 17357536
[TBL] [Abstract][Full Text] [Related]
4. Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.
Karahan B; Argon A; Yıldırım M; Vardar E
Int J Clin Exp Pathol; 2015; 8(4):4044-53. PubMed ID: 26097592
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
Zafirellis K; Agrogiannis G; Zachaki A
APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
[TBL] [Abstract][Full Text] [Related]
6. Correlation between inducible nitric oxide synthase and cyclooxygenase-2 expression in human colorectal adenocarcinoma: a cross-sectional study.
Habibollahi P; Jamshidiha M; Daryani NE; Jahanzad I; Ghahremani MH; Ostad SN
Pathol Oncol Res; 2010 Sep; 16(3):327-35. PubMed ID: 20069397
[TBL] [Abstract][Full Text] [Related]
7. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
Yao HB; Wu AG; Chen YJ; Tang BH
Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1524-8. PubMed ID: 16361154
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance and prognostic value of EphA3 and CD133 expression in colorectal carcinoma.
Xi HQ; Zhao P
J Clin Pathol; 2011 Jun; 64(6):498-503. PubMed ID: 21415057
[TBL] [Abstract][Full Text] [Related]
9. Expression of cyclooxygenase-2 protein in colorectal carcinomas.
Joo YE; Kim HS; Min SW; Lee WS; Park CH; Park CS; Choi SK; Rew JS; Kim SJ
Int J Gastrointest Cancer; 2002; 31(1-3):147-54. PubMed ID: 12622426
[TBL] [Abstract][Full Text] [Related]
10. [Association of 5-lipoxygenase expression and clinicopathological factors in colorectal carcinoma].
Li YC; Wang DX; Li CS; Ye ZP; Wu ZM; Chen JH
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Sep; 16(9):895-7. PubMed ID: 24062003
[TBL] [Abstract][Full Text] [Related]
11. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression.
Zhao LH; Lin QL; Wei J; Huai YL; Wang KJ; Yan HY
Int J Clin Exp Pathol; 2015; 8(1):692-701. PubMed ID: 25755763
[TBL] [Abstract][Full Text] [Related]
12. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
Zhang H; Sun XF
Am J Gastroenterol; 2002 Apr; 97(4):1037-41. PubMed ID: 12003384
[TBL] [Abstract][Full Text] [Related]
14. Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas.
Okayasu I; Mitomi H; Yamashita K; Mikami T; Fujiwara M; Kato M; Oshimura M
J Cancer Res Clin Oncol; 1998; 124(8):444-9. PubMed ID: 9750021
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
[TBL] [Abstract][Full Text] [Related]
16. [Relationship between PUMA and BIM expression in colorectal cancer and tumor invasion, metastasis and prognosis].
Yuan H; Tu SL; He XJ
Zhonghua Wai Ke Za Zhi; 2013 Jun; 51(6):547-51. PubMed ID: 24091272
[TBL] [Abstract][Full Text] [Related]
17. Hierarchical investigating the predictive value of p53, COX2, EGFR, nm23 in the post-operative patients with colorectal carcinoma.
Du P; Xu B; Zhang D; Shao Y; Zheng X; Li X; Xiong Y; Wu C; Jiang J
Oncotarget; 2017 Jan; 8(1):954-966. PubMed ID: 27888614
[TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of COX-2 expression in patients with colorectal cancer.
Yamac D; Celenkoglu G; Coskun U; Akyurek N; Akcali Z; Dursun A; Koybasioglu F
Pathol Res Pract; 2005; 201(7):497-502. PubMed ID: 16164044
[TBL] [Abstract][Full Text] [Related]
19. Elevation of cyclooxygenase-2 is related to lymph node metastasis in adenocarcinoma of uterine cervix.
Kang S; Kim MH; Park IA; Kim JW; Park NH; Kang D; Yoo KY; Kang SB; Lee HP; Song YS
Cancer Lett; 2006 Jun; 237(2):305-11. PubMed ID: 16111807
[TBL] [Abstract][Full Text] [Related]
20. Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.
Lam AK; Ong K; Ho YH
Hum Pathol; 2008 Apr; 39(4):599-604. PubMed ID: 18284933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
